Acomplia Ireland UK France Italy Europe patient - Rimonabant works by blocking receptors called cannabinoid-1 receptors (CB1). These are found in the brain, fat tissue, digestive system, liver and muscles. The CB1 receptors are part of a system in the body called the endocannabinoid system. This system has only recently been discovered and explored. It is involved in regulating energy balance, sugar and fat metabolism and body weight.
International Press Release Publishing for free in 15 languages across 22 countries
Press Releases
Google-Suche:
 

Blog blogger.com

You are not logged in, so we don't know your blog. Please fill in the data to access your blog at blogger.com. The entered information will be stored for this session.
Username
Password
Blog-URL
 
Title of your post
Text of your post
SUBCATEGORIES
Senior Health
 
 
Pressreleases by authors
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z